Company Filing History:
1 out of 15 
1 out of 1 Years Active: 2007
Title: Christopher John Secombes: Innovator in Monoclonal Antibody Development
Introduction
Christopher John Secombes is a notable inventor based in Balmedie, GB. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for both human and animal health, showcasing the versatility of his inventions.
Latest Patents
Secombes holds a patent for a monoclonal antibody designated as 3F1H10, which neutralizes the viral hemorrhagic septicemia virus (VHSV). This invention involves a non-infectious nucleic acid construct designed to express a recombinant antibody or antibody fragment within a host cell. The antibody molecule provides protection against various pathogens, allergens, or toxins, and can be utilized in a range of hosts, including humans and fish.
Career Highlights
Throughout his career, Secombes has been associated with prestigious institutions such as Aberdeen University and Dianova. His work at these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Secombes has collaborated with notable colleagues, including Charles Cunningham and Niels Lorenzen. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Christopher John Secombes is a distinguished inventor whose work in monoclonal antibody development has the potential to enhance health outcomes for both humans and animals. His contributions to biotechnology are noteworthy and continue to influence the field.